Cephalon Acquisitions, 7 Deals Between 20 | MergrĬephalon, Inc. Medical Information For healthcare professionals or patients with specific medical questions about SYNRIBO, please contact us at the number below or by using the appropriate information request link. Contact Us | SYNRIBO (omacetaxine mepesuccinate)ġ- 610- 344- 0200 Product Information Request. is a global pharmaceutical company specializing in the development. 41 Moores Road Frazer, PA 19355 USA Phone: (610) 344-0200 PDF Respiratory - Pharma & Medtech Business Intelligence Contact Us - TREANDA® (bendamustine HCl) Injection We only collect personally identifiable information about you if you choose to give it to us. Teva Investigator Sponsored Studies ProgramĪt Teva, we understand that protecting your privacy is important.
Contact us - BENDEKA® (bendamustine HCl) injectionĬontact us. Of 2,000 employees at its facilities in North Wales, Horsham, West Chester, Frazer and New Britain in Pennsylvania, Teva will retain 500 and 600 workers at its West Chester research facility and over 100 employees to support operations and distribution in northeastern Pennsylvania, the newspaper reported, citing a company spokesperson.Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. The company previously shut down its offices in New York and Washington and has also been planning to consolidate seven offices into one location. Teva disclosed plans in December 2017 to eliminate 14,000 jobs worldwide and plans to cut costs by $3 billion by the end of 2019. The company chose New Jersey over other locations attracted by a $40 million package of tax breaks, The Philadelphia Inquirer reported. base, according to a news release from the office of N.J.
The Israeli drugmaker expects to transfer and create 843 jobs and retain 232 existing positions at its new U.S. headquarters to Parsippany-Troy Hills, N.J., from North Wales, Pa.
0 kommentar(er)
